• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶和金属蛋白酶组织抑制因子与大鼠脑再灌注后的血脑屏障开放有关。

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

作者信息

Rosenberg G A, Estrada E Y, Dencoff J E

机构信息

Departments of Neurology, Cell Biology and Physiology, and Neuroscience, University of New Mexico, Albuquerque, NM 87131, USA

出版信息

Stroke. 1998 Oct;29(10):2189-95. doi: 10.1161/01.str.29.10.2189.

DOI:10.1161/01.str.29.10.2189
PMID:9756602
Abstract

BACKGROUND AND PURPOSE

Reperfusion disrupts cerebral capillaries, causing cerebral edema and hemorrhage. Middle cerebral artery occlusion (MCAO) induces the matrix-degrading metalloproteinases, but their role in capillary injury after reperfusion is unknown. Matrix metalloproteinases (MMPs) and tissue inhibitors to metalloproteinases (TIMPs) modulate capillary permeability. Therefore, we measured blood-brain barrier (BBB) permeability, brain water and electrolytes, MMPs, and TIMPs at multiple times after reperfusion.

METHODS

Adult rats underwent MCAO for 2 hours by the suture method. Brain uptake of 14C-sucrose was measured from 3 hours to 14 days after reperfusion. Levels of MMPs and TIMPs were measured by zymography and reverse zymography, respectively, in contiguous tissues. Other rats had water and electrolytes measured at 3, 24, or 48 hours after reperfusion. Treatment with a synthetic MMP inhibitor, BB-1101, on BBB permeability and cerebral edema was studied.

RESULTS

Brain sucrose uptake increased after 3 and 48 hours of reperfusion, with maximal opening at 48 hours and return to normal by 14 days. There was a correlation between the levels of gelatinase A at 3 hours and the sucrose uptake (P<0.05). Gelatinase A (MMP-2) was maximally increased at 5 days, and TIMP-2 was highest at 5 days. Gelatinase B and TIMP-1 were maximally elevated at 48 hours. The inhibitor of gelatinase B, TIMP-1, was also increased at 48 hours. Treatment with BB-1101 reduced BBB opening at 3 hours and brain edema at 24 hours, but neither was affected at 48 hours.

CONCLUSIONS

The initial opening at 3 hours correlated with gelatinase A levels and was blocked by a synthetic MMP inhibitor. The delayed opening, which was associated with elevated levels of gelatinase B, failed to respond to the MMP inhibitor, suggesting different mechanisms of injury for the biphasic BBB injury.

摘要

背景与目的

再灌注会破坏脑毛细血管,导致脑水肿和出血。大脑中动脉闭塞(MCAO)会诱导基质降解金属蛋白酶,但它们在再灌注后毛细血管损伤中的作用尚不清楚。基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)调节毛细血管通透性。因此,我们在再灌注后的多个时间点测量了血脑屏障(BBB)通透性、脑水和电解质、MMPs以及TIMPs。

方法

成年大鼠通过缝线法进行2小时的MCAO。在再灌注后3小时至14天测量大脑对14C-蔗糖的摄取。分别通过酶谱法和反向酶谱法测量相邻组织中MMPs和TIMPs的水平。其他大鼠在再灌注后3、24或48小时测量水和电解质。研究了合成MMP抑制剂BB-1101对BBB通透性和脑水肿的治疗作用。

结果

再灌注3小时和48小时后大脑蔗糖摄取增加,48小时时达到最大开放,14天时恢复正常。3小时时明胶酶A水平与蔗糖摄取之间存在相关性(P<0.05)。明胶酶A(MMP-2)在5天时最大程度增加,TIMP-2在5天时最高。明胶酶B和TIMP-1在48小时时最大程度升高。明胶酶B的抑制剂TIMP-1在48小时时也增加。用BB-1101治疗可在3小时时减少BBB开放,在24小时时减轻脑水肿,但在48小时时两者均未受影响。

结论

3小时时的初始开放与明胶酶A水平相关,并被合成MMP抑制剂阻断。与明胶酶B水平升高相关的延迟开放对MMP抑制剂无反应,提示双相性BBB损伤存在不同的损伤机制。

相似文献

1
Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.基质金属蛋白酶和金属蛋白酶组织抑制因子与大鼠脑再灌注后的血脑屏障开放有关。
Stroke. 1998 Oct;29(10):2189-95. doi: 10.1161/01.str.29.10.2189.
2
Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.局灶性脑缺血再灌注后小鼠体内活化基质金属蛋白酶-9的早期出现及血脑屏障破坏
Brain Res. 1999 Sep 18;842(1):92-100. doi: 10.1016/s0006-8993(99)01843-0.
3
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.实验性胆汁性肝纤维化中基质金属蛋白酶及其抑制剂之间的平衡改变
Am J Pathol. 1998 Dec;153(6):1895-902. doi: 10.1016/S0002-9440(10)65703-3.
4
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.大鼠局灶性脑缺血后基质金属蛋白酶表达增加:抑制基质金属蛋白酶-9可减小梗死灶大小。
Stroke. 1998 May;29(5):1020-30. doi: 10.1161/01.str.29.5.1020.
5
Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.妊娠早期基质金属蛋白酶-2、基质金属蛋白酶-9及金属蛋白酶组织抑制剂向子宫内各腔隙的分泌。
Mol Hum Reprod. 1999 Apr;5(4):376-81. doi: 10.1093/molehr/5.4.376.
6
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.在大鼠局灶性缺血中,合成基质金属蛋白酶抑制剂可逆转基质金属蛋白酶介导的脑血管紧密连接蛋白的破坏。
J Cereb Blood Flow Metab. 2007 Apr;27(4):697-709. doi: 10.1038/sj.jcbfm.9600375. Epub 2006 Jul 19.
7
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.类固醇对多发性硬化症患者脑脊液基质金属蛋白酶的影响:与血脑屏障损伤的关系。
Neurology. 1996 Jun;46(6):1626-32. doi: 10.1212/wnl.46.6.1626.
8
Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.合成明胶酶抑制剂通过抑制明胶酶介导的 ZO-1 降解来减轻电磁脉冲诱导的血脑屏障破坏。
Toxicology. 2011 Jul 11;285(1-2):31-8. doi: 10.1016/j.tox.2011.03.019. Epub 2011 Apr 8.
9
Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.血流中断在动态体外血脑屏障模型中诱导白细胞介导的基质金属蛋白酶/金属蛋白酶组织抑制因子失衡:促炎细胞因子的作用
Am J Physiol Cell Physiol. 2006 Oct;291(4):C740-9. doi: 10.1152/ajpcell.00516.2005. Epub 2006 May 17.
10
Matrix metalloproteinases and their inhibitors in gastric cancer.胃癌中的基质金属蛋白酶及其抑制剂
Gut. 1998 Dec;43(6):791-7. doi: 10.1136/gut.43.6.791.

引用本文的文献

1
Role of autophagy in neurotoxic protein's clearance following post-ischemic stroke: where we are and what we know?自噬在缺血性中风后神经毒性蛋白清除中的作用:我们目前的进展与所知情况?
Mol Brain. 2025 Jul 8;18(1):60. doi: 10.1186/s13041-025-01201-1.
2
The Triad of Blood-Brain Barrier Integrity: Endothelial Cells, Astrocytes, and Pericytes in Perinatal Stroke Pathophysiology.血脑屏障完整性三联征:围产期卒中病理生理学中的内皮细胞、星形胶质细胞和周细胞
Int J Mol Sci. 2025 Feb 22;26(5):1886. doi: 10.3390/ijms26051886.
3
MMP-9 inhibitor SB-3CT improves neurological outcomes in ischemic stroke mice by modulation of astrocytic lipid metabolism.
基质金属蛋白酶-9抑制剂SB-3CT通过调节星形胶质细胞脂质代谢改善缺血性中风小鼠的神经功能结局。
Acta Pharmacol Sin. 2025 Mar 11. doi: 10.1038/s41401-025-01505-x.
4
The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies.单克隆抗体疗法对创伤性脑损伤病理的相关性及影响
Biomedicines. 2024 Nov 26;12(12):2698. doi: 10.3390/biomedicines12122698.
5
Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.受体蛋白酪氨酸磷酸酶β/ζ的药理学抑制作用可减少APP/PS1小鼠海马中的Aβ斑块和神经炎症。
Front Pharmacol. 2024 Dec 6;15:1506049. doi: 10.3389/fphar.2024.1506049. eCollection 2024.
6
The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection.他汀类药物的多效性作用:对神经血管单元调节和血脑屏障保护的全面探索
Mol Med. 2024 Dec 20;30(1):256. doi: 10.1186/s10020-024-01025-0.
7
Sigma-1 receptor signaling: A potential therapeutic approach for ischemic stroke.西格玛-1受体信号传导:缺血性中风的一种潜在治疗方法。
J Cereb Blood Flow Metab. 2024 Dec;44(12):1430-1440. doi: 10.1177/0271678X241281547. Epub 2024 Sep 9.
8
Electroacupuncture ameliorates blood-brain barrier disruption after ischemic stroke through histone acetylation regulation at the matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 2 genes.电针对缺血性脑卒中后血脑屏障破坏的改善作用是通过基质金属蛋白酶 9 和金属蛋白酶组织抑制剂 2 基因的组蛋白乙酰化调节实现的。
J Tradit Chin Med. 2024 Aug;44(4):734-744. doi: 10.19852/j.cnki.jtcm.20240610.004.
9
Four-hour-delayed 3D-FLAIR MRIs in patients with acute unilateral peripheral vestibulopathy.急性单侧外周前庭病变患者的四小时延迟 3D-FLAIR MRI。
Ann Clin Transl Neurol. 2024 Aug;11(8):2030-2039. doi: 10.1002/acn3.52123. Epub 2024 Jun 14.
10
The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials.氧化应激在缺血性脑卒中期间血脑屏障破坏中的作用:临床试验中的抗氧化剂。
Biochem Pharmacol. 2024 Oct;228:116186. doi: 10.1016/j.bcp.2024.116186. Epub 2024 Mar 30.